BDSX Q1 2026 Earnings EPS Surprises to the Upside Amid Operational Progress Black Diamond Therapeutics BDTX Q1 2026 Earnings EPS Beat Fails to Lift Stock as Pipeline Uncertainty Lingers MUSA Q1 2026 Earnings Massive EPS Beat Defies Light Revenue Disclosure Stock Slips Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 ADUS Q1 2026 Earnings EPS Beats Estimates by 242 Stock Edges Higher Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting